Medicare

Relievant Medsystems Announces Favorable Coverage Policy from Cigna Healthcare for the Intracept Procedure

Staff June 20, 2023

MINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic...

LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study

Staff June 13, 2023

LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 150th bipolar depression patient has...

Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando

Staff June 13, 2023

AdventHealth Orlando performs their first implant of Guardian™ System, revolutionizing cardiac care in Central FloridaEATONTOWN, N.J. and ORLANDO, Fla., June...

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023

Staff June 9, 2023

LONDON and SALT LAKE CITY, June 09, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled...

Alignment Health Appoints 3 New Executives to Further Drive Strategic Growth Nationally

Staff June 6, 2023

Todd Macaluso, David Milligan and Joe Kanatzar will be responsible for expanding premier care access for seniors throughout the US...

Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assay’s Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer

Staff June 2, 2023

New data emphasizes the value of MRD testing in predicting survival outcomes and informing the personalized treatment of patients with...

Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference

Staff May 30, 2023

SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its...

Data Presented at the 2023 American Academy of Dental Sleep Medicine and the American Thoracic Society Meetings Further Validate ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea

Staff May 30, 2023

PLEASANTON, Calif., May 30, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a leading CPAP alternative for the...

Updated Linvoseltamab (BCMAxCD3) Data from Pivotal Trial Demonstrates Early, Deep and Durable Responses in Patients with Heavily Pre-treated Multiple Myeloma

Staff May 26, 2023

71% objective response rate, with 59% of patients achieving a very good partial response or better at the recommended 200...

Fianlimab (LAG-3 inhibitor) Combined with Libtayo® (cemiplimab) Shows Clinically Meaningful and Durable Tumor Responses Across Key Advanced Melanoma Patient Populations

Staff May 26, 2023

Data demonstrate objective response rates from 56% to 63% across three independent cohorts of advanced melanoma patients – about double...

BrainsWay Announces Appointment of Ido Marom as CFO

Staff May 23, 2023

BURLINGTON, Mass. and JERUSALEM, May 23, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...

BioCardia Announces Timing of the Next Data Safety Monitoring Board Meeting for the CardiAMP Cell Therapy in Heart Failure Pivotal Study

Staff May 23, 2023

SUNNYVALE, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a developer of cellular and cell-derived therapeutics for the treatment...

iCAD’s ProFound AI Breast Suite Wins U.S. General Services Administration’s AI Healthcare Challenge Award

Staff May 18, 2023

Company presented portfolio of breast cancer detection, density assessment and risk evaluation solutions at the competition, focused on improving health...

BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights

Staff May 17, 2023

BURLINGTON, Mass. and JERUSALEM, May 17, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...

ReWalk Robotics Reports First Quarter 2023 Financial Results

Staff May 11, 2023

On-Track Start to Fiscal Year with Progress in Advancing Reimbursement Coverage for Medicare Beneficiaries MARLBOROUGH, Mass. BERLIN and YOKNEAM ILLIT, Israel,...

New Long-Term Real-World Research Confirms Xoft Skin eBx is as Safe and Effective as Mohs Surgery

Staff May 11, 2023

98.9% of patients treated with Xoft remained recurrence-free at a median follow-up of 7.6 years, according to recent study published...

Neuronetics Reports Record First Quarter 2023 Financial and Operating Results

Staff May 9, 2023

MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology...

Intra-Cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update

Staff May 4, 2023

Q1 2023 total revenues of $95.3 million, compared to $35.0 million in the same period in 2022 CAPLYTA Q1 2023...

Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation

Staff May 3, 2023

- Transaction values Avertix at an enterprise value of $195 million- Avertix developed the Guardian™ System, the first and only...

Nanox.ARC Imaging System Receives FDA Clearance, Pioneering a New Era in Medical Imaging

Staff May 1, 2023

Nanox.ARC Image of the Nanox ARC Nanox.ARC Image of the Nanox ARCNanox.ARC presents high powered digital X-ray tubes for 3D...